BioCentury
ARTICLE | Clinical News

V.I. Technologies preclinical data

March 1, 1999 8:00 AM UTC

VITX presented data showing that its Pc4 system was able to clear red blood cells of HIV, BVDV (a model for hepatitis C virus) and the parasites that cause malaria and Chagas disease to below the limit of detection in vitro and in animal models. The compounds used are not toxic or mutagenic and do not affect red blood cell performance, VITX said. The data were presented at the Blood Safety and Screening conference in McLean, Va. ...